The inhibition of growth and down-regulation of gonadotropin releasing hormone (GnRH) receptor in ααT3-1 cents by GnRH agonist

Anti-Cancer Drugs

Volumn 8, Issue 4, 1997, Pages 369-375

  Kakar, Sham S ^b   Nath, Sati ^b   Bunn, Jason ^b   Jennes, Lothar ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cancer; Gonadotropin releasing hormone; Gonadotropin releasing hormone receptor; Growth; Receptor

Indexed keywords

GONADORELIN AGONIST; GONADORELIN RECEPTOR; GONADORELIN[6 DEXTRO LYSINE]; MESSENGER RNA; PROTIRELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HYPOPHYSIS TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030927526     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704000-00009     Document Type: Article

References (32)

1. Clayton RN. Gonadotropin-releasing hormone: its actions and receptors. J Endocrinol 1989; 120: 11-9.
2. Kakar SS, Rahe CH, Jennes L. Gonadotropin releasing hormone (GnRH) receptors: molecular cloning, tissue distribution and regulation of gene expression in pituitary, brain and tumor. Mol Androl 1996; 8: 95-125.
3. Klijn JMG, Foekens JA. Extrapituitary actions. In: Vickey BH, Lunenfel B, eds. Basic aspects. GnRH analogues in cancer and human reproduction. Dordrecht: Kluwar 1989: 71-84.
4. Henzel MR. Gonadotropin-releasing hormone and its analogues: from laboratory to bedside. Clin Obstet Gynecol 1993; 36: 617-35.
5. Schally AV, Comaru-Schally AM, Redding TW. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers. Proc Soc Exp Biol Med 1984; 175: 259-81.
6. Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynecological cancers. Hum Reprod 1994; 9: 1364-79.
7. Harvey HA, Lipton A, Max DT. LHRH analogs for human mammary carcinoma. In: Vickery BH, Nester JJ, Hafez ES, eds. LHRH and its analogs: contraceptive and therapeutic applications. Lancaster: MTP Press 1984: 329-35.
8. Klijn JG, de Jong FH, Lamberts SW, Blankenstein MA. LHRH-agonist treatment in clinical and experimental human breast cancer. J Steroid Biochem 1985; 23: 867-73.
9. Harris AL, Carmichael J, Cantwell BMJ, Dowsett M. Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer. Br J Cancer 1989; 59: 97-9.
10. Plowman PN, Nicholson RI, Walker KJ. Remission of post-menopausal breast cancer during treatment with the luteinizing hormone-releasing hormone agonist IC 118630. Br J Cancer 1986; 54: 903-9.
11. Limonta P, Dondi D, Moretti RM, Fermo D, Garattini E, Motta M. Expression of luteinizing hormone-releasing hormone mRNA in the human prostate cancer cell line LNCaP. J Clin Endocrinol Metab 1993; 76: 797-800.
12. Segal-Abramson T, Kitroser H, Levy J, Schally AV, Sharoni Y. Direct effects of luteinizing hormone-releasing hormone agonists and antagonist on MCF-7 mammary cancer cells. Proc Natl Acad Sci USA 1992; 89: 2336-9.
13. Yano T, Pinski J, Radulovic S, Schally AV. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 1994; 91: 1701-5.
14. Emons G, Ortmann, O, Becker M, et al. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res 1993; 53: 5439-46.
15. Eidne KA, Flanagan CA, Millar RP. Gonadotropin releasing-hormone binding sites in human carcinoma. Science 1985; 229: 989-91.
16. Eidne KA, Flanagan CA, Harris NS, Millar RP Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J Clin Endocrinol Metab 1987; 64: 425-32.
17. Pati D, Habibi HR. Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones. Endocrinology 1995; 136: 75-84.
18. Emons G, Schroder B, Ortmann O, Westphalen S, Schulz K-D, Schally AV High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 1993; 77: 1458-64.
19. Kaiser UB, Jakubowiak A, Stainberger A, Chin WW. Regulation of rat gonadotropin-releasing hormone receptor mRNA levels in vivo and in vitro. Endocrinology 1993; 133: 931-4.
20. Halmos G, Schally AV, Pinski J, Vadillo-Buenfil M, Groot K. Down regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LHRH antagonist cetrorelix. Proc Natl Acad Sci USA 1996; 93: 2398-402.
21. Pinski J, Lamharzi N, Halmos G, et al. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Endocrinology 1996; 137: 3430-6.
22. Wu JC, Sealfon SC, Miller WL. Gonadal hormones and gonadotropin-releasing hormone (GnRH) alter messenger ribonucleic acid levels for GnRH receptors in sheep. Endocrinology 1994; 134: 1846-50.
23. Tsutsumi M, Zhou W, Millar RP, et al. Cloning and functional expression of a mouse gonadotropin-releasing hormone. Mol Endocrinol 1992; 6: 1163-9.
24. Reinhart J, Mertz LM, Catt KJ. Molecular cloning and expression of cDNA encoding the murine gonadotropin-releasing hormone receptor. J Biol Chem 1992; 267: 21281-4.
25. Windle JJ, Weiner RI, Mellon PL. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 1990; 4: 597-603.
26. Kakar SS, Jennes L. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Let 1995; 98: 57-62.
27. Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun 1992; 189: 289-95.
28. Kakar SS, Grantham K, Musgrove LC, Devor D, Sellers SC, Neill JD. Rat gonadotropin-releasing hormone (GnRH) receptor: tissue expression and hormonal regulation of its mRNA. Mol Cell Endocrinol 1994; 101: 151-7.
29. Irmer G, Burger C, Muller R, et al. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma. Cancer Res 1995; 55: 817-22.
30. Lerrant Y, Kotter ML, Bergametti F, et al. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin β-subunit genes in normal and castrated rat pituitary. Endocrinology 1995; 136: 2803-8.
31. Mason DR, Arora KK, Mertz LM, Catt KJ. Homologous down-regulation of gonadotropin-releasing hormone receptor sites and messenger ribonucleic acids transcripts in αT3-1 cells. Endocrinology 1994; 135: 1165-70.
32. Tsutsumi M, Laws SC, Sealfon SC. Homologous up-regulation of the gonadotropin-releasing hormone receptor in αT3-1 cells is associated with unchanged receptor messenger RNA (mRNA) levels and altered mRNA activity. Mol Endocrinol 1993; 7: 1625-33.